glp-1 and menopause Microdosing for Perimenopause Menopause: A Hormone-Aware Metabolic Framework GLP-1 Weight Loss in Menopause:

Tirzepatide was more efficacious in reducing body weight

Certain foods have been identified as potential GLP-1 boosters, offering a more holistic approach to managing appetite and blood sugar levels

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

Learn how an unlikely discovery in a venomous lizard led to one of todays most influential drugs and why future breakthroughs still depend on the freedom to explore.

Satiety regulation (reduces appetite, aiding in weight loss)

Currently, the Food and Drug Administration (FDA) has approved seven GLP-1 prescription medications:GENERIC NAMEBRAND NAMEFORMSSemaglutideOzempicRybelsusWegovyInjectionOral PillTirzepatideMounjaroZepboundInjectionLiraglutideVictozaSaxendaInjectionDulaglutideTrulicityInjectionExenatideByettaInjectionLixisenatideAdlyxinInjectionOrforglipron*Foundayo*Oral Pill*Non-peptide, small molecule When used in addition to a reduced calorie diet and increased physical activity, these medications are FDA approved for one or more of the following:Improving blood sugar levels in adults with T2D.Reducing excess body weight and keep it off long term in:Adults and children aged 12 years and older with obesity.Adults who are overweight who also have at least one weight-related medical problem (such as high blood pressure, diabetes, or high cholesterol)Reducing the risk of major adverse cardiovascular events in adults with T2D who have heart disease or are at high risk for these events.Can Service Members use GLP-1 prescription medications?GLP-1 medications are only available with a prescription from a qualified healthcare provider